XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statement of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 01, 2022
Jan. 02, 2021
Dec. 28, 2019
Income Statement [Abstract]      
Revenue (Notes 1 and 12) $ 786,579 $ 635,028 $ 704,644
Costs and Operating Expenses:      
Cost of revenue 449,214 357,722 410,884
Selling, general, and administrative expenses 208,787 181,905 192,525
Research and development expenses 11,403 11,298 10,884
Impairments and other costs, net (Notes 1 and 8) 465 2,979 2,528
Total Costs and Operating Expenses 669,869 553,904 616,821
Operating Income 116,710 81,124 87,823
Interest Income 267 181 213
Interest Expense (4,821) (7,423) (12,755)
Other Expense, Net (Note 3) (104) (195) (6,359)
Income Before Provision for Income Taxes 112,052 73,687 68,922
Provision for Income Taxes (Note 5) 27,171 17,948 16,358
Net Income 84,881 55,739 52,564
Net Income Attributable to Noncontrolling Interest (838) (543) (496)
Net income attributable to Kadant $ 84,043 $ 55,196 $ 52,068
Earnings per Share Attributable to Kadant (Note 13)      
Basic (in dollars per share) $ 7.26 $ 4.81 $ 4.63
Diluted (in dollars per share) $ 7.21 $ 4.77 $ 4.54
Weighted Average Shares (Note 13)      
Basic (in shares) 11,579 11,482 11,235
Diluted (in shares) 11,655 11,564 11,457